| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 07/29/2004 | US20040147495 Sapogenin derivatives, their synthesis and use, and methods based upon their use |
| 07/29/2004 | US20040147490 Immunosuppressants |
| 07/29/2004 | US20040147482 Cubane derivatives as metabotropic glutamate receptor antagonists and process for their preparation |
| 07/29/2004 | US20040147449 For inhibition of vascularization and for cancer therapy |
| 07/29/2004 | US20040147010 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative, potential pathogenic gram-positive bacteria |
| 07/29/2004 | US20040146504 Anti-IgE vaccines |
| 07/29/2004 | US20040146502 Use of organic compounds |
| 07/29/2004 | CA2512320A1 Contact lens and eye drop rewetter compositions and their uses |
| 07/28/2004 | EP1441033A2 Eukaryotic gene expression cassette based on Herpes simplex virus |
| 07/28/2004 | EP1440159A2 Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma |
| 07/28/2004 | EP1440091A1 Nogo receptor homologues and their use |
| 07/28/2004 | EP1440083A2 Molecules |
| 07/28/2004 | EP1440073A1 Pde9 inhibitors for treating cardiovascular disorders |
| 07/28/2004 | EP1440062A1 An efficient synthesis of 5-heteroatom-containing-pyrazoles |
| 07/28/2004 | EP1439837A1 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 07/28/2004 | EP1317264B1 Combination of lipoic acids and conjugated acids for treating diabetic disorders |
| 07/28/2004 | EP1175445B1 Specific antibodies and antibody fragments for tgfbeta1 |
| 07/28/2004 | EP0927183B1 Spirocyclic metalloprotease inhibitors |
| 07/28/2004 | EP0823895B1 Fatty acid esters as bioactive compounds |
| 07/28/2004 | CN1516739A Use of HMG fragments as anti-inflammatory agents |
| 07/28/2004 | CN1516698A Arylindenopyridines with PDE inhibiting activity |
| 07/28/2004 | CN1516687A 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 07/28/2004 | CN1516588A Combination of brimonidine and timolol for topical ophthalmic use |
| 07/28/2004 | CN1516580A Sulfonamides |
| 07/28/2004 | CN1515562A Phenyl-and aminophenyl-alkyl sulfonamide and urea derivative |
| 07/28/2004 | CN1515559A Phenyl-and aminophenyl-alkyl sulfonamide and urea derivative |
| 07/28/2004 | CN1515554A Intermediate compound for producing 2-amino-6-(2-substituted-4-phenoxy) substituted pyridine compound |
| 07/28/2004 | CN1515548A Oxaminic acid used as thyroid gland receptor ligand and its derivative |
| 07/28/2004 | CN1515315A Stable composition containing epidermal growth factor and bletilla tuber extract |
| 07/28/2004 | CN1515291A Oral liquor for curing ophthalmokopia |
| 07/28/2004 | CN1515288A Medicine for curing catarct, its preparation method by using scutellaria root and medicine application |
| 07/28/2004 | CN1515271A Erlong Fucong Pill for curing deafness |
| 07/28/2004 | CN1159036C Eye drops |
| 07/28/2004 | CN1159013C Use of combination of vitamins for the treatment of pruritus and relating to itching and/or non-infective inflammatory disorders |
| 07/28/2004 | CN1159000C Buccal delivery system |
| 07/28/2004 | CN1158994C Topcial suspension formulations containing cirporfloxacin and dexa methasone |
| 07/27/2004 | US6767917 Diuretics; cardiovascular, kidney and brain disorder treatment; antitumor, antiallergen, and antiasthmatic agents |
| 07/22/2004 | WO2004060385A1 Ophthalmic therapeutic composition |
| 07/22/2004 | WO2004060373A1 Therapeutic agent for wet age-related macular degeneration |
| 07/22/2004 | WO2004060348A2 Ophthalmic and ophthalmological use of a complex nutritive base in an aqueous medium |
| 07/22/2004 | WO2004060266A2 Eye-drop vaccine containing copolymer poly-ye for therapeutic immunization |
| 07/22/2004 | WO2004060265A2 Eye-drop vaccine containing copolymer 1 for therapeutic immunization |
| 07/22/2004 | WO2003103583A8 A method for using tethered bis(polyhydroxyphenyls) and o-alkyl derivatives thereof in treating inflammatory conditions of the central nervous system |
| 07/22/2004 | WO2003087304A3 Tri-substituted heteroaryls and methods of making and using the same |
| 07/22/2004 | WO2003006002A9 Compositions and methods of administering tubulin binding agents for the treatment of ocular diseases |
| 07/22/2004 | US20040143003 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors |
| 07/22/2004 | US20040142988 Bladder diseases; bone diosrders; central nerevous system diosrders |
| 07/22/2004 | US20040142982 Urea derivatives as integrin alpha 4 antagonists |
| 07/22/2004 | US20040142952 Triazoloquinazoline and pyrazolotriazolopyrimidine derivatives, medicinal compositions, adenosine a3 receptor affinity agents, ocular tension lowering agents, preparations for preventing and treating glaucoma and method of lowering ocular tension |
| 07/22/2004 | US20040142947 Pyrrolopyrimidines |
| 07/22/2004 | US20040142934 treatment of rheumatoid arthritis and/or pain; INHIBIT activity of VEGF receptor tyrosine kinase and VEGF-dependent cell proliferation |
| 07/22/2004 | US20040142932 treating diseases and conditions caused or exacerbated by unregulated p38 MAP Kinase activity |
| 07/22/2004 | US20040142920 acute or chronic transplant rejection or inflammatory or autoimmune diseases |
| 07/22/2004 | US20040142919 Benzazepinone alpha vintegrin receptor antagonists |
| 07/22/2004 | US20040142877 Ligands of the $g(a)v$g(b)6 integrin |
| 07/22/2004 | US20040142860 Central nervous system-derived immune privilege factor and uses thereof |
| 07/22/2004 | US20040142349 kit for detecting a risk of cancer, coronary or cerebrovascular disease, hypertension, type 2 diabetes, dementia, joint arthrosis, cataract, or sensitivity to organophosphorus compounds |
| 07/22/2004 | US20040142038 Three layer artificial tear formulation |
| 07/22/2004 | US20040141949 Treatment of mucositis |
| 07/22/2004 | US20040141917 Antibodies to truncated VEGF-D and uses thereof |
| 07/22/2004 | CA2512735A1 Eye-drop vaccine containing copolymer 1 for therapeutic immunization |
| 07/21/2004 | EP1439176A1 Pyrimidone compounds and pharmaceutical compositions containing the same |
| 07/21/2004 | EP1439174A1 4-imidazolin-2-one compounds |
| 07/21/2004 | EP1438973A1 Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists |
| 07/21/2004 | EP1438942A1 An otorhinological drug delivery device |
| 07/21/2004 | EP1438583A2 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays |
| 07/21/2004 | EP1438316A1 Phosphonic acid compounds as inhibitors of serine proteases |
| 07/21/2004 | EP1438308A1 N-azabicyclo-substituted hetero-bicyclic carboxamides as nachr agonists |
| 07/21/2004 | EP1438302A1 New sulfonamide derivatives as d3-receptor agonists |
| 07/21/2004 | EP1438296A2 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity |
| 07/21/2004 | EP1438295A2 Azole derivatives and pharmaceutical compositions containing them |
| 07/21/2004 | EP1438293A2 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 07/21/2004 | EP1438291A1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 07/21/2004 | EP1438281A2 Functionalized stilbene derivatives as improved vascular targeting agents |
| 07/21/2004 | EP1438104A1 Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists |
| 07/21/2004 | EP1438052A1 INHIBITORS OF HUMAN PHOSPHATIDYL−INOSITOL 3−KINASE DELTA |
| 07/21/2004 | EP1438046A2 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation, and methods for their use |
| 07/21/2004 | EP1438037A1 Methods for treating dry eye by a combination of an antiinflammatory steroid and a muc-1 secretagogue |
| 07/21/2004 | EP1438022A1 Drug release system for controlled therapy |
| 07/21/2004 | EP1320521B1 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives of cyclopentyl-heptan(en)oic acid as therapeutic agents |
| 07/21/2004 | EP1228029B1 Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders |
| 07/21/2004 | EP1226137B1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
| 07/21/2004 | EP1144369B1 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
| 07/21/2004 | EP0958282B1 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines |
| 07/21/2004 | CN1514879A Moraxella (branhamella) catarrhalis antigens |
| 07/21/2004 | CN1514735A Ophthalmic composition comprising hyaluronic acid |
| 07/21/2004 | CN1513991A Recombination human alkaline fiber forming cell growth factor gene and its nonfusion expression product, production method and application |
| 07/21/2004 | CN1513467A Small pellet of extraction of kudzu vine, and its prepn. method |
| 07/21/2004 | CN1513456A Eye drop contg. pazoxacin methanesulphonate, its prepn. method and its anti-infective function |
| 07/21/2004 | CN1513442A Prepn. and use of mixture of arginine-burfenum |
| 07/21/2004 | CN1158276C Phenyl-and pyridyl-tetrahydro-pyridines having TNF inhibiting activity |
| 07/21/2004 | CN1158266C Compounds |
| 07/21/2004 | CN1158084C Long-acting heparin intraocular slow-released system |
| 07/21/2004 | CN1158073C Application of protein kinase C inhibitor in preparing medicine |
| 07/20/2004 | US6765022 Cyclohexylamine derivatives as subtype selective nmda receptor antagonists |
| 07/20/2004 | US6765003 3-Arylsulfonyl-2 (substituted methyl) propanoic acid derivatives as matrix metalloproteinase inhibitors |
| 07/20/2004 | US6764683 Stimulation of hematopoiesis in patients undergoing cytotoxic cancer chemotherapy; preventing mucositis; cytoprotection |
| 07/20/2004 | CA2254731C Inhibition of matrix metalloproteases by 2-substituted-4-(4-substitutedphenyl)-4-oxobutyric acids |
| 07/20/2004 | CA2231194C Pharmaceutical formulation |
| 07/15/2004 | WO2004058273A1 Use of rimexolone in the treatment of dry eye |